Early prediction of outcome in score-identified, postcardiac surgical patients at high risk for sepsis, using soluble tumor necrosis factor receptor-p55 concentrations
- 1 April 1996
- journal article
- research article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 24 (4) , 596-600
- https://doi.org/10.1097/00003246-199604000-00008
Abstract
To investigate the prognostic value of increased serum concentrations of soluble tumor necrosis factor (TNF) receptors in patients at high risk for sepsis. Prospective study. Cardiac surgical intensive care unit in a University Hospital. Those 27 of 870 consecutive postcardiac surgical patients who met a previously validated high-risk criterion for imminent sepsis (Acute Physiology and Chronic Health Evaluation II [APACHE II] score of more than equals 24 on the first postoperative day [day 1]). In this population, systemic inflammatory response syndrome was present in 96% of the patients and the inhospital mortality rate was 30%. In addition, ten postcardiac surgical patients with an uncomplicated course (mortality rate 0%) were studied for comparison. Blood sampling for measurements of serum concentrations of TNF and soluble TNF receptors 55 kilodalton (TNF receptor-p55) and 75 kilodalton (TNF receptor-p75) on days 1, 2, 3, and 5. Compared with the ten patients with an uncomplicated course (group A), the high-risk patients had significantly higher baseline (day 1) serum concentrations of soluble TNF receptor-p55 (9.2 vs. 4.2 ng/mL) and soluble TNF receptor-p75 (9.2 vs. 5.5 ng/mL). These high-risk patients could be further differentiated into two subgroups: one (B) with a prompt decrease in APACHE II score and a good prognosis (mortality rate 0%) and another (C) with a persisting high risk of sepsis and mortality rate (40%, p less than .05). Although baseline APACHE II score was similar in both high-risk subgroups, soluble TNF receptor-p55 concentrations were significantly higher in subgroup C compared with subgroup B already at baseline (10.7 vs. 4.7 ng/mL). The receiver operating characteristic curve for subgroup classification by soluble TNF receptor-p55 was in a discriminating position with an area (0.773 plus minus 0.096), confirming soluble TNF receptor-p55 as a predictor of mortality. TNF and soluble TNF receptor-p75 concentrations were less predictive at baseline. This study suggests that increased soluble TNF receptor-p55 concentrations in the serum of postcardiac surgical patients allow earlier prognostication of subsequent hospital course than APACHE II scores alone. This study further suggests that the combination of physiologic scores and cytokine receptor measurements could improve the predictive power of early postoperative risk stratification.Keywords
This publication has 23 references indexed in Scilit:
- Release of Soluble Receptors for Tumor Necrosis Factor in Clinical Sepsis and Experimental EndotoxemiaThe Journal of Infectious Diseases, 1993
- Detection of Tumor Necrosis Factor Soluble Receptor p55 in Blood Samples from Healthy and Endotoxemic HumansThe Journal of Infectious Diseases, 1993
- Mediators of septic shockCritical Care Medicine, 1993
- Soluble Tumor Necrosis Factor Receptors Correlate with Parasitemia and Disease Severity in Human MalariaThe Journal of Infectious Diseases, 1992
- Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo.Proceedings of the National Academy of Sciences, 1992
- A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor.Proceedings of the National Academy of Sciences, 1990
- Characterization in vitro of a human tumor necrosis factor-binding protein. A soluble form of a tumor necrosis factor receptor.Journal of Clinical Investigation, 1990
- Molecular cloning and expression of the human 55 kd tumor necrosis factor receptorCell, 1990
- Isolation and characterization of a tumor necrosis factor binding protein from urineEuropean Journal of Haematology, 1989
- APACHE IICritical Care Medicine, 1985